-
AT-406 (SM-406): Workflow-Optimized Apoptosis Activation in
2026-04-25
AT-406 (SM-406) delivers precise, robust apoptosis pathway activation in cancer cell systems, enabling both direct cytotoxicity and enhanced chemosensitization. This guide translates recent structural breakthroughs and validated protocols into actionable experimental workflows for oncology research teams.
-
Sisomicin: Protocols and Troubleshooting for Antibacterial R
2026-04-24
Sisomicin, a potent aminoglycoside antibiotic, empowers advanced in vitro and in vivo workflows targeting resistant Gram-negative and Gram-positive bacteria. Explore stepwise protocols, data-driven optimizations, and troubleshooting tips that maximize reliability and reproducibility in infection modeling and antibacterial screening.
-
MDL 28170: A Selective Calpain Inhibitor for Neuroprotection
2026-04-24
MDL 28170 is a selective calpain inhibitor with nanomolar potency, enabling mechanistic studies in neuroprotection and apoptosis assays. Its blood-brain barrier permeability and robust inhibition of calpain and cathepsin B support translational research on ischemia-reperfusion injury and neurodevelopmental disorders.
-
Corynoline Induces Apoptosis in Osteosarcoma via Src/JNK Pat
2026-04-23
This study elucidates how corynoline, an isoquinoline alkaloid, inhibits osteosarcoma cell growth by inducing G2/M cell cycle arrest and promoting mitochondrial apoptosis through the Src/JNK signaling pathway. The findings highlight the therapeutic potential of targeting Src/JNK signaling in osteosarcoma and provide experimental models for apoptosis detection.
-
Ibrexafungerp: Translational Leverage Against Resistant Cand
2026-04-23
This article explores Ibrexafungerp (MK 3118) from mechanistic foundation through experimental validation and translational relevance, emphasizing its differentiated activity against resistant Candida species, including fluconazole- and echinocandin-resistant isolates. Blending rigorously referenced data with strategic guidance, the article provides protocol recommendations, competitive positioning, and a forward-looking perspective for researchers advancing antifungal therapies from bench to bedside.
-
Z-LEHD-FMK: Precision Irreversible Caspase-9 Inhibitor Workf
2026-04-22
Z-LEHD-FMK enables high-precision dissection of mitochondria-mediated apoptosis in both cancer and neuroprotection models, offering robust cytoprotective and mechanistic insights. APExBIO delivers this irreversible caspase-9 inhibitor optimized for advanced apoptosis assays, streamlining experimental workflows while supporting reproducible results.
-
Epigenetic Induction of PDK1 Drives TKI Resistance in Cancer
2026-04-22
This study uncovers how KDM3A and METTL16 orchestrate epigenetic modifications that elevate PDK1 expression, promoting resistance to EGFR-TKIs and tumor progression in several cancer types. The findings suggest the KDM3A/METTL16/PDK1 axis as a promising target and biomarker for overcoming drug resistance in oncology.
-
MK-4827 (Niraparib) in BRCA-Mutant Cancer Research: Advanced
2026-04-21
MK-4827 (Niraparib) is a benchmark tool for dissecting DNA damage repair inhibition, especially in BRCA-mutant and resistant cancer models. This article delivers actionable protocols, troubleshooting strategies, and highlights the latest advances—including hyperthermia-induced sensitization—for maximizing research impact.
-
Neticonazole Hydrochloride: Dual-Action Imidazole Antifungal
2026-04-21
Neticonazole Hydrochloride is a dual-action imidazole antifungal with both antifungal and antitumor efficacy. It inhibits fungal cell membrane synthesis and suppresses exosome secretion, a process implicated in colorectal cancer progression. Clinically validated as a first-line topical therapy for cutaneous candidiasis, it offers reproducible results in both mycology and oncology research.
-
Procainamide Hydrochloride: Applied Workflows in Cardiac and
2026-04-20
Procainamide Hydrochloride stands out as a rigorously validated cardiac sodium channel blocker and DNMT1 inhibitor, offering researchers a dual-utility tool for cardiac electrophysiology and epigenetic modulation. This guide details experimental workflows, advanced applications, and troubleshooting insights for maximizing assay reliability with APExBIO’s Procainamide Hydrochloride.
-
RNA Pol II Inhibition Triggers Apoptosis via PDAR, Not mRNA
2026-04-20
Harper et al. (2025) reveal that cell death following RNA polymerase II (Pol II) inhibition is triggered by a regulated apoptotic pathway, not by passive mRNA or protein decay. This paradigm-shifting work defines the Pol II degradation-dependent apoptotic response (PDAR), fundamentally altering our understanding of how transcriptional inhibitors induce cell death and providing new context for apoptosis research in cancer models.
-
HSP70 Modulation of TDP-43 Condensation Under Poly-PR Stress
2026-04-19
Agnihotri et al. reveal that poly-PR dipeptides linked to C9ORF72 mutations drive NEAT1-dependent TDP-43 nuclear condensation, with HSP70 chaperones maintaining condensate fluidity. Prolonged stress leads to HSP70 delocalization, TDP-43 oligomerization, and increased cytotoxicity, highlighting potential intervention points for ALS pathogenesis.
-
Tiamulin (Thiamutilin): Mechanism, Benchmarks, and Veterinar
2026-04-18
Tiamulin (Thiamutilin) is a pleuromutilin veterinary antibiotic with dual antibacterial and anti-inflammatory properties. Its efficacy in pigs and poultry is underpinned by precise ribosomal inhibition and TNF-α pathway modulation. This dossier provides rigorous, benchmarked guidance for research and protocol design.
-
Protease Inhibitor Cocktail EDTA-Free: Precision in Protein
2026-04-17
The Protease Inhibitor Cocktail (EDTA-Free, 100X in DMSO) from APExBIO safeguards protein samples without the risks of EDTA, enabling phosphorylation studies and complex preservation in challenging workflows. Its optimized inhibitor blend delivers robust, reproducible protection for applications from Western blotting to kinase assays.
-
Protein A/G Magnetic Beads: Practical Guidelines for IP & Ch
2026-04-16
Protein A/G Magnetic Beads streamline antibody purification and immunoprecipitation from complex samples by combining recombinant Protein A and Protein G on nanoscale magnetic supports. They are best suited for workflows requiring high selectivity and reduced background, such as co-immunoprecipitation and chromatin IP. These beads are not intended for diagnostic or medical use and require proper QC and storage to maintain performance.